PAR 1.81% $2.72 paradigm biopharmaceuticals limited..

Hi Mozzarc,I'm absolutely not disagreeing that the PAR/PPS story...

  1. 111 Posts.
    lightbulb Created with Sketch. 25
    Hi Mozzarc,

    I'm absolutely not disagreeing that the PAR/PPS story is a compelling one, and I have no doubt at all as to the drug's efficacy, having got hold of some for my wife (it worked a treat).

    The point that I'm making is that we should be a good deal more realistic when doing the numbers on potential revenue flow, and, imo, disregard some of the hype coming out of various quarters.

    Consider: approximately 20% of the population has doctor diagnosed arthritis of one kind or another (say 5m Australians). The cost of treating those individuals with even a single course of PPS (and you actually need continuing treatment, as this isn't a one-off), at $2k a pop would be $10 billion dollars!! This is about 50% more than the entire annual cost of operating the current PBS!!

    So, quite obviously, I would have thought, there is absolutely zero chance that the Australian government would be willing to pay anything remotely like that sort of money, and neither would any other government anywhere in the world.

    Anyway, charging $2k per course of treatment with a drug that costs about 1% of that amount (say $20) to manufacture, is quite obviously a non-starter.

    Love the company, and absolutely agree about the potential size of the prize, but let's all keep a sense of perspective here.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
$2.72
Change
-0.050(1.81%)
Mkt cap ! $525.1M
Open High Low Value Volume
$2.79 $2.88 $2.71 $806.5K 289.9K

Buyers (Bids)

No. Vol. Price($)
2 4405 $2.72
 

Sellers (Offers)

Price($) Vol. No.
$2.75 600 1
View Market Depth
Last trade - 16.10pm 22/10/2019 (20 minute delay) ?
(live)
Last
$2.73
  Change
-0.050 ( 1.71 %)
Open High Low Volume
$2.83 $2.83 $2.72 14294
Last updated 14.16pm 22/10/2019 (live) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.